ALXA is simply preparing to dilute. They have no cash for advancing any pipeline drugs. There are only two realistic ways they do NOT dilute: 1. Adasuve sales are so stupendous out the gate that cash is rolling in hand over fist. 2. Anoher biotech company partners with them and funds the next pipeline drug. Dilution is inevitable here.